Vericel Corp reports results for the quarter ended June 30 - Earnings Summary

Vericel

30/07/2026 19:07

Vericel Corp VCEL.OQ reported quarterly adjusted earnings of 4 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -1 cents.  The mean expectation of eight analysts for the quarter was for a loss of 3 cents per share. Wall Street expected results to range from -6 cents tozero cents per share.
Revenue rose 22.5% to $77.50 million from a year ago; analysts expected $72.69 million. 
Vericel Corp's reported EPS for the quarter was 4 cents​.
The company reported quarterly net income of $2.2 million.
Vericel Corp shares had risen by 4.8% this quarter and gained 29.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 240.6% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy" 
Wall Street's median 12-month price target for Vericel Corp is $55.00, about 15.2% above its last closing price of $46.62
This summary was machine generated from LSEG data July 30 at 06:07 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.03
0.04
Beat
Mar. 31 2026 
-0.15
-0.12
Beat
Dec. 31 2025 
0.39
0.45
Beat
Sep. 30 2025 
-0.01
0.10
Beat